BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944 | -15.3% | 328,900 | +49.0% | 0.00% | 0.0% |
| Q2 2023 | $1,115 | +171.3% | 220,700 | +1.5% | 0.00% | +100.0% |
| Q1 2023 | $411 | +3.5% | 217,500 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $397 | -99.9% | 220,613 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $368,000 | -45.0% | 217,700 | -20.0% | 0.00% | 0.0% |
| Q2 2022 | $669,000 | -8.7% | 272,002 | +2.8% | 0.00% | 0.0% |
| Q1 2022 | $733,000 | -64.3% | 264,491 | -31.4% | 0.00% | -66.7% |
| Q4 2021 | $2,054,000 | +355.4% | 385,400 | +1972.0% | 0.00% | +200.0% |
| Q1 2021 | $451,000 | -59.7% | 18,600 | -29.8% | 0.00% | 0.0% |
| Q2 2020 | $1,118,000 | – | 26,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $17,046,000 | 0.60% |
| NEA Management Company, LLC | 3,449,845 | $29,186,000 | 0.35% |
| MPM BioImpact LLC | 248,506 | $2,102,000 | 0.33% |
| Artal Group S.A. | 1,646,517 | $13,930,000 | 0.31% |
| RA Capital Management | 2,589,904 | $21,911,000 | 0.30% |
| Bellevue Group AG | 3,463,000 | $29,297,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 760,128 | $6,431,000 | 0.13% |
| Ikarian Capital, LLC | 150,484 | $1,272,000 | 0.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,000 | $371,000 | 0.09% |
| Virtus ETF Advisers LLC | 16,600 | $140,000 | 0.06% |